Research progress of ablation combined with immunotherapy for prostate cancer
10.13929/j.issn.1672-8475.2020.04.012
- Author:
Ying JI
1
Author Information
1. Department of Radiology, Shanghai General Hospital
- Publication Type:Journal Article
- Keywords:
Autoimmunity;
Catheter ablation;
Prostatic neoplasms
- From:
Chinese Journal of Interventional Imaging and Therapy
2020;17(4):243-246
- CountryChina
- Language:Chinese
-
Abstract:
Prostate cancer is one of the most common malignancies in men. Ablation therapy represented by cryoablation is effective in treating prostate cancer. However, currently, how to improve long-term curative effect and reduce local recurrence are the main problems. Ablation therapy can activate the body's anti-tumor immune response, in order to interfere with residual, tumor recurrence and distant metastatic lesions after ablation. The research advancements of ablation combined with immunotherapy for prostate cancer were reviewed in this article.
